PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Rare mutations linked with catastrophic aortic aneurysms

2010-11-19
(Press-News.org) TAAD causes thousands of deaths in the United States each year. Although timely surgical repair of aneurysms can prevent death, thoracic aneurysms are often asymptomatic until dissection (tearing of the vessel wall), and there are few recognized risk factors that can be used for screening. "Prospective identification of patients at risk for TAAD using a genetic strategy will be critical to prevent sudden deaths from this treatable disease," explains senior study author Dr. John W. Belmont from Baylor College of Medicine.

To begin to unravel the genetic origins of TAAD, lead author Dr. Siddharth Prakash and colleagues at Baylor and Dr. Dianna Milewicz and colleagues at the University of Texas Health Science Center in Houston performed a genome-wide analysis of hundreds of sporadic TAAD cases. The researchers identified 47 copy-number variant (CNV) regions in the TAAD samples when compared with control samples. A CNV is an excess or absence in copies of a particular gene. Previous research has demonstrated that CNVs are linked with many different human diseases.

Specifically, Dr. Prakash and colleagues found that genes within the TAAD CNVs regulate the ability of smooth muscle to firmly adhere within the vessel walls and to contract as the aorta expands and recoils. Importantly, the mutations were linked with molecules whose disruption has been shown to cause inherited TAAD. "Our observations provide strong support for the involvement of multiple rare CNVs that disrupt smooth muscle adhesion or contraction and contribute to both sporadic and familial TAAD. In addition, our findings have implications for other adult-onset cardiovascular disorders," concludes Dr. Belmont.

### The primary author for this research is John W. Belmont, Baylor College of Medicine

The first author for this research is Siddharth K. Prakash, Baylor College of Medicine


ELSE PRESS RELEASES FROM THIS DATE:

FDA review on transgenic salmon too narrow

2010-11-19
DURHAM, N.C. -- The review process being used by the Food and Drug Administration to assess the safety of a faster-growing transgenic salmon fails to weigh the full effects of the fish's widespread production, according to analysis by a Duke University-led team in this week's Science. The salmon, whose genome contains inserted genes from two other fish species, could become the first genetically modified animal approved for human consumption in the United States. The FDA held two days of hearings in September to assess the fish's human and environmental health risks. ...

It takes a village: Mechanism alerts neighbors to amplify immune response

2010-11-19
The pathogen Shigella flexneri invades the cells that line the gut and causes Shigellosis, a disorder characterized by diarrhea and sometimes even death in humans. S. flexneri subverts the normal immune response of the host by interfering with the ability of the infected cell to secrete chemicals called chemokines that stimulate inflammation. Inflammation is a complex response to pathogens that attracts white blood cells to destroy the bacteria. Despite the documented ability of S. flexneri to suppress inflammation in infected cells, intestinal cells do secrete large amounts ...

Researchers uncover surprise link between weird quantum phenomena

Researchers uncover surprise link between weird quantum phenomena
2010-11-19
Researchers have uncovered a fundamental link between the two defining properties of quantum physics. Stephanie Wehner of Singapore's Centre for Quantum Technologies and the National University of Singapore and Jonathan Oppenheim of the United Kingdom's University of Cambridge published their work today in the latest edition of the journal Science. The result is being heralded as a dramatic breakthrough in our basic understanding of quantum mechanics and provides new clues to researchers seeking to understand the foundations of quantum theory. The result addresses the ...

Panama Canal, Panama City at risk of large earthquake, says new research

2010-11-19
Panama Canal, PanNew data suggest that the Limon and Pedro Miguel faults in Central Panama have ruptured both independently and in unison over the past 1400 years, indicating a significant seismic risk for Panama City and the Panama Canal, according to research published today by the Bulletin of the Seismological Society of America (BSSA). The Panama Canal is undergoing expansion to allow for greater traffic of larger ships, scheduled for completion by 2014. As part of a seismic hazard characterization for the Panama Canal Authority (ACP) expansion project, Rockwell, ...

Planet from another galaxy discovered

Planet from another galaxy discovered
2010-11-19
Over the last 15 years, astronomers have detected nearly 500 planets orbiting stars in our cosmic neighbourhood, but none outside our Milky Way has been confirmed [1]. Now, however, a planet with a minimum mass 1.25 times that of Jupiter [2] has been discovered orbiting a star of extragalactic origin, even though the star now finds itself within our own galaxy. It is part of the so-called Helmi stream — a group of stars that originally belonged to a dwarf galaxy that was devoured by our galaxy, the Milky Way, in an act of galactic cannibalism about six to nine billion years ...

Paleovirology expanded: Non-retroviral virus fragments found in animal genomes

2010-11-19
Understanding the evolution of life-threatening viruses like influenza, Ebola and dengue fever, could help us to minimize their impact. New research points the way to a fossil record of viruses that have insinuated themselves into the genomes of insects and other animals, providing clues about their evolutionary history. The findings, published online on November 18 in the open-access journal PLoS Genetics, could enable scientists to elucidate general principles in virus evolution from their genetic "fossils", which in turn could inform approaches for controlling disease. Robert ...

Scripps Research scientists report molecular structure of dopamine receptor

2010-11-19
LA JOLLA, CA – November 16, 2010 – A team led by scientists at The Scripps Research Institute has solved the structure of one of the receptors that responds to the neurotransmitter dopamine. Although dopamine transmission is essential to normal brain functioning, the biological assembly of the molecules involved in this crucial neuronal interplay had not been known—until now. The work was reported in the November 19, 2010, issue of the journal Science. In the new study, whose authors included collaborators from Weill Cornell Medical College, Receptos, the National Institute ...

Paw prints and feces offer new hope for saving tigers

Paw prints and feces offer new hope for saving tigers
2010-11-19
As experts gather in St Petersburg, Russia for next week's Tiger Summit, fewer than 3,200 tigers survive in the wild worldwide. More than half live in India, where they are spread over a vast area (100,000 sq km) of forest. According to Dr Yadvendradev Jhala of the Wildlife Institute of India, lead author of the new study: "Tigers are cryptic, nocturnal and occur at low densities so they are extremely difficult to monitor. Unless we know how many tigers are left in the wild, and whether their numbers are increasing or decreasing, we will not be able to conserve them." Until ...

Cough medicine could help doctors identify how breast cancer patients metabolize tamoxifen

2010-11-19
Cough medicine could be used as way of predicting how well individual patients metabolise tamoxifen used in the treatment of their breast cancer, according to new research presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Friday). The findings suggest that it could be possible to use cough suppressant syrup as a probe, which would enable doctors to identify patients with altered metabolism and use this information to improve individual treatment, making it more effective and reducing the chances of side-effects. ...

Researchers find new target for stopping tumors developing their own blood supply

2010-11-19
Researchers have found that a newly developed drug, which is aimed at a particular receptor involved in the development of blood vessels that sustain tumour growth, is active in patients with advanced cancers and, in some cases, has halted the progress of the disease. The drug, ACE-041, targets a different molecular pathway to other anti-angiogenesis drugs and may provide a new option to treat cancer. Results from a phase I clinical study of ACE-041 were presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Friday). ...

LAST 30 PRESS RELEASES:

Eighty-five years of big tree history available in one place for the first time

MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery

Health and economic air quality co-benefits of stringent climate policies

How immune cells deliver their deadly cargo

How the brain becomes a better listener: How focus enhances sound processing

Processed fats found in margarines unlikely to affect heart health

Scientists discover how leukemia cells evade treatment

Sandra Shi MD, MPH, named 2025 STAT Wunderkind

Treating liver disease with microscopic nanoparticles

Chemicals might be hitching a ride on nanoplastics to enter your skin

Pregnant patients with preexisting high cholesterol may have elevated CV risk

UC stroke experts discuss current and future use of AI tools in research and treatment

The Southern Ocean’s low-salinity water locked away CO2 for decades, but...

OHSU researchers develop functional eggs from human skin cells

Most users cannot identify AI bias, even in training data

Hurricane outages: Analysis details the where, and who, of increased future power cuts

Craters on surface of melanoma cells found to serve as sites for tumor killing

Research Spotlight: Mapping overlooked challenges in stroke recovery

Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US

Cannabis laws and opioid use among commercially insured patients with cancer diagnoses

Research Spotlight: Surprising gene mutation in brain’s immune cells linked to increased Alzheimer’s risk

Missing molecule may explain Down syndrome

Donor diabetes and 1-year Descemet membrane endothelial keratoplasty success rate

Endothelial cell loss 1 year after successful DMEK in the diabetes endothelial keratoplasty study

Overactive Runx1 gene triggers early disc degeneration linked to aging

NYU Langone Health chair of ophthalmology, Dr. Kathryn Colby, honored with Castroviejo Medal at AAO 2025

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

FAU’s Queen Conch Lab receives prestigious international award

Post-traumatic vasospasm: An overlooked threat after brain injury

Scientists smash record in stacking semiconductor transistors for large-area electronics

[Press-News.org] Rare mutations linked with catastrophic aortic aneurysms